相关实验视频
Updated: Jul 9, 2025

12:19
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
60.5K
没有CDK4/6活动的Rb失活和外部信号的非正规途径协调细胞循环进入,没有CDK4/6活动
Mimi Zhang1, Sungsoo Kim1,2, Hee Won Yang3,4
1Department of Pathology and Cell Biology, Columbia University, New York, NY, 10032, USA.
Nature communications
|November 29, 2023
概括
哺乳动物细胞具有非正规的视网膜母细胞瘤 (Rb) 蛋白失活路径,绕过循环素依赖的激酶4和6 (CDK4/6). 这一途径与c-Myc和Cip/Kip水平一起,调节细胞增殖和静止.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
背景情况:
- 循环素依赖性激酶4和6 (CDK4/6) 是细胞增殖的关键调节者,主要通过非活化视网膜母细胞瘤 (Rb) 蛋白.
- 哺乳动物细胞拥有绕过Rb无活化的CDK4/6的机制,这表明了细胞循环控制的其他途径.
研究的目的:
- 阐明Rb无活化及其与外部信号交互的非正规途径.
- 了解控制细胞循环进入和维持静止状态的机制.
主要方法:
- 在静止细胞中研究Rb蛋白稳定性.
- 通过mitogenic和压力信号通路对E2F活动调节的分析.
- 评估不同细胞状态中的c-Myc和Cip/Kip蛋白水平.
主要成果:
- 非酸化的Rb蛋白在静止细胞中本质上是不稳定的,使其能够绕过正规的CDK4/6调节.
- 线粒体信号稳定c-Myc,增加E2F活动以促进细胞增殖,而压力信号调节Cip/Kip水平.
- 癌症中c-Myc的升高有助于CDK4/6抑制剂的耐药性;通过c-Myc和Cip/Kip调制,分化的细胞保持静止状态.
结论:
- 存在一种非正规的Rb失活路径,涉及Rb内在的不稳定性和外部信号.
- 细胞增殖和静止是微生物和压力信号的相互作用微调,影响c-Myc和Cip/Kip水平.
- 了解这些途径为癌症适应和细胞分化提供了洞察力.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K

